Literature DB >> 22023506

Investigating the antimalarial action of 1,2,4-trioxolanes with fluorescent chemical probes.

Carmony L Hartwig1, Erica M W Lauterwasser, Sumit S Mahajan, Jonathan M Hoke, Roland A Cooper, Adam R Renslo.   

Abstract

The 1,2,4-trioxolanes are a new class of synthetic peroxidic antimalarials currently in human clinical trials. The well-known reactivity of the 1,2,4-trioxolane ring toward inorganic ferrous iron and ferrous iron heme is proposed to play a role in the antimalarial action of this class of compounds. We have designed structurally relevant fluorescent chemical probes to study the subcellular localization of 1,2,4-trioxolanes in cultured Plasmodium falciparum parasites. Microscopy experiments revealed that a probe fluorescently labeled on the adamantane ring accumulated specifically in digestive vacuole-associated neutral lipid bodies within the parasite while an isosteric, but nonperoxidic, congener did not. Probes fluorescently labeled on the cyclohexane ring showed no distinct localization pattern. In their subcellular localization and peroxidative effects, 1,2,4-trioxolane probes behave much like artemisinin-based probes studied previously. Our results are consistent with a role for adamantane-derived carbon-centered radicals in the antimalarial action of 1,2,4-trioxolanes, as hypothesized previously on the basis of chemical reactivity studies.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22023506      PMCID: PMC3236788          DOI: 10.1021/jm2012003

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  29 in total

1.  C11-BODIPY(581/591), an oxidation-sensitive fluorescent lipid peroxidation probe: (micro)spectroscopic characterization and validation of methodology.

Authors:  Gregor P C Drummen; Lydia C M van Liebergen; Jos A F Op den Kamp; Jan A Post
Journal:  Free Radic Biol Med       Date:  2002-08-15       Impact factor: 7.376

Review 2.  A medicinal chemistry perspective on artemisinin and related endoperoxides.

Authors:  Paul M O'Neill; Gary H Posner
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

3.  The antimalarial drug artemisinin alkylates heme in infected mice.

Authors:  Anne Robert; Françoise Benoit-Vical; Catherine Claparols; Bernard Meunier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-09       Impact factor: 11.205

4.  Evidence for a common non-heme chelatable-iron-dependent activation mechanism for semisynthetic and synthetic endoperoxide antimalarial drugs.

Authors:  Paul A Stocks; Patrick G Bray; Victoria E Barton; Mohammed Al-Helal; Michael Jones; Nuna C Araujo; Peter Gibbons; Stephen A Ward; Ruth H Hughes; Giancarlo A Biagini; Jill Davies; Richard Amewu; Amy E Mercer; Gemma Ellis; Paul M O'Neill
Journal:  Angew Chem Int Ed Engl       Date:  2007       Impact factor: 15.336

5.  Artemisinin activity against Plasmodium falciparum requires hemoglobin uptake and digestion.

Authors:  Nectarios Klonis; Maria P Crespo-Ortiz; Iveta Bottova; Nurhidanatasha Abu-Bakar; Shannon Kenny; Philip J Rosenthal; Leann Tilley
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-27       Impact factor: 11.205

6.  Simple and inexpensive fluorescence-based technique for high-throughput antimalarial drug screening.

Authors:  Martin Smilkstein; Nongluk Sriwilaijaroen; Jane Xu Kelly; Prapon Wilairat; Michael Riscoe
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

7.  Identification of an antimalarial synthetic trioxolane drug development candidate.

Authors:  Jonathan L Vennerstrom; Sarah Arbe-Barnes; Reto Brun; Susan A Charman; Francis C K Chiu; Jacques Chollet; Yuxiang Dong; Arnulf Dorn; Daniel Hunziker; Hugues Matile; Kylie McIntosh; Maniyan Padmanilayam; Josefina Santo Tomas; Christian Scheurer; Bernard Scorneaux; Yuanqing Tang; Heinrich Urwyler; Sergio Wittlin; William N Charman
Journal:  Nature       Date:  2004-08-19       Impact factor: 49.962

8.  Food vacuole-associated lipid bodies and heterogeneous lipid environments in the malaria parasite, Plasmodium falciparum.

Authors:  Katherine E Jackson; Nectarios Klonis; David J P Ferguson; Akinola Adisa; Con Dogovski; Leann Tilley
Journal:  Mol Microbiol       Date:  2004-10       Impact factor: 3.501

9.  Peroxide bond-dependent antiplasmodial specificity of artemisinin and OZ277 (RBx11160).

Authors:  Marcel Kaiser; Sergio Wittlin; Angela Nehrbass-Stuedli; Yuxiang Dong; Xiaofang Wang; Andrew Hemphill; Hugues Matile; Reto Brun; Jonathan L Vennerstrom
Journal:  Antimicrob Agents Chemother       Date:  2007-06-11       Impact factor: 5.191

10.  Accumulation of artemisinin trioxane derivatives within neutral lipids of Plasmodium falciparum malaria parasites is endoperoxide-dependent.

Authors:  Carmony L Hartwig; Andrew S Rosenthal; John D'Angelo; Carol E Griffin; Gary H Posner; Roland A Cooper
Journal:  Biochem Pharmacol       Date:  2008-10-19       Impact factor: 5.858

View more
  14 in total

Review 1.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

2.  Drug delivery to the malaria parasite using an arterolane-like scaffold.

Authors:  Shaun D Fontaine; Benjamin Spangler; Jiri Gut; Erica M W Lauterwasser; Philip J Rosenthal; Adam R Renslo
Journal:  ChemMedChem       Date:  2014-10-14       Impact factor: 3.466

3.  Ferrous iron-dependent delivery of therapeutic agents to the malaria parasite.

Authors:  Sumit S Mahajan; Jiri Gut; Philip J Rosenthal; Adam R Renslo
Journal:  Future Med Chem       Date:  2012-12       Impact factor: 3.808

4.  Trioxolane-Mediated Delivery of Mefloquine Limits Brain Exposure in a Mouse Model of Malaria.

Authors:  Erica M W Lauterwasser; Shaun D Fontaine; Hao Li; Jiri Gut; Kasiram Katneni; Susan A Charman; Philip J Rosenthal; Matthew Bogyo; Adam R Renslo
Journal:  ACS Med Chem Lett       Date:  2015-10-02       Impact factor: 4.345

Review 5.  Hemozoin and antimalarial drug discovery.

Authors:  Kim Y Fong; David W Wright
Journal:  Future Med Chem       Date:  2013-08       Impact factor: 3.808

6.  Ferrous iron-dependent drug delivery enables controlled and selective release of therapeutic agents in vivo.

Authors:  Edgar Deu; Ingrid T Chen; Erica M W Lauterwasser; Juan Valderramos; Hao Li; Laura E Edgington; Adam R Renslo; Matthew Bogyo
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-21       Impact factor: 11.205

7.  Intrinsic fluorescence properties of antimalarial pyrido[1,2-a]benzimidazoles facilitate subcellular accumulation and mechanistic studies in the human malaria parasite Plasmodium falciparum.

Authors:  Constance M Korkor; Larnelle F Garnie; Leah Amod; Timothy J Egan; Kelly Chibale
Journal:  Org Biomol Chem       Date:  2020-11-04       Impact factor: 3.876

Review 8.  Synthesis of five- and six-membered cyclic organic peroxides: Key transformations into peroxide ring-retaining products.

Authors:  Alexander O Terent'ev; Dmitry A Borisov; Vera A Vil'; Valery M Dembitsky
Journal:  Beilstein J Org Chem       Date:  2014-01-08       Impact factor: 2.883

9.  In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate.

Authors:  Fabian Baumgärtner; Joëlle Jourdan; Christian Scheurer; Benjamin Blasco; Brice Campo; Pascal Mäser; Sergio Wittlin
Journal:  Malar J       Date:  2017-01-25       Impact factor: 2.979

10.  Monoclonal Antibodies That Recognize the Alkylation Signature of Antimalarial Ozonides OZ277 (Arterolane) and OZ439 (Artefenomel).

Authors:  Joëlle Jourdan; Hugues Matile; Ellen Reift; Oliver Biehlmaier; Yuxiang Dong; Xiaofang Wang; Pascal Mäser; Jonathan L Vennerstrom; Sergio Wittlin
Journal:  ACS Infect Dis       Date:  2015-09-28       Impact factor: 5.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.